finanzwire.de

Search

HIKMA (LON:HIK) Director/PDMR Shareholding

Transparency directive : regulatory news

17/05/2018 13:10

18/05/2018 13:01
18/05/2018 07:00
17/05/2018 13:45
17/05/2018 13:10
03/05/2018 09:00
01/05/2018 13:38
26/04/2018 13:40
25/04/2018 10:41
24/04/2018 09:00
20/04/2018 09:00
Hikma Pharmaceuticals Plc  -  HIK   

Director/PDMR Shareholding

Released 13:10 17-May-2018

 

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 17 May 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 11 May 2016 under the 2014 Executive Incentive Plan ("EIP") Element B which was completed on 16 May 2018.  

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Hussein Arkhagha

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Hussein Arkhagha

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on
16 May 2018 under the 2014 EIP Element B.

c)

Price(s) and volume(s)

Price(s): £nil

Volume(s): 7,749

d)

Aggregated information

N/A

e)

Date of the transaction

16 May 2018

f)

Place of the transaction

London Stock Exchange (XLON)

Bryan Hotston

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bryan Hotston

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Shares acquired from vesting of the conditional awards on
16 May 2018 under the 2014 EIP Element B.

c)

Price(s) and volume(s)

Price(s): £13.18

Volume(s): 1,860

d)

Aggregated information

Volume: 1,860

Price: £13.18

Total: £24,514.80

e)

Date of the transaction

16 May 2018

f)

Place of the transaction

London Stock Exchange (XLON)

 

Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760